Birk Poller

1.7k citations

35 papers · 1.3k indexed · h-index 20

Impact in

Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
Oncology top 5%
- Drug Transport and Resistance Mechanisms

Papers in ⓘ

Pharmacology 15
- Pharmacogenetics and Drug Metabolism 11
- Drug-Induced Hepatotoxicity and Protection 6
Oncology 24
- Drug Transport and Resistance Mechanisms 23
- Pancreatic and Hepatic Oncology Research 3

Co-authors: Jörg Huwyler (10 shared papers)Jürgen Drewe (7 shared papers)Heike Gutmann (5 shared papers)Stephan Krähenbühl (2 shared papers)Gian Camenisch (12 shared papers)Alfred H. Schinkel (4 shared papers)Annett Kunze (4 shared papers)Seng Chuan Tang (3 shared papers)
Journals: Drug Metabolism and Disposition (8 papers)Journal of Pharmaceutical Sciences (3 papers)Clinical Pharmacology & Therapeutics (2 papers)Clinical and Translational Science (2 papers)European Journal of Pharmaceutical Sciences (2 papers)
Partner nations: Switzerland United States Netherlands

In The Last Decade

Birk Poller

35 papers receiving 1.3k citations

Peers

Countries citing papers authored by Birk Poller

Since Specialization

Citations

This map shows the geographic impact of Birk Poller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birk Poller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birk Poller more than expected).

Fields of papers citing papers by Birk Poller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birk Poller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birk Poller. The network helps show where Birk Poller may publish in the future.

Co-authors

The 25 scholars most cited alongside Birk Poller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Birk Poller Line = papers co-authored together Birk Poller links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The human brain endothelial cell line hCMEC/D3 as a human blood‐brain barrier model for drug transport studies Journal of Neurochemistry ·Birk Poller, Heike Gutmann, Stephan Krähenbühl, Babette B. Weksler, Ignacio A. Romero, Pierre‐Olivier Couraud, Gérald Tuffin, Jürgen Drewe, Jörg Huwyler	2008	262
2	Regulation of BCRP (ABCG2) and P-Glycoprotein (ABCB1) by Cytokines in a Model of the Human Blood–Brain Barrier Cellular and Molecular Neurobiology ·Birk Poller, Jürgen Drewe, Stephan Krähenbühl, Jörg Huwyler, Heike Gutmann	2009	144
3	Brain accumulation of sunitinib is restricted by P‐glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration International Journal of Cancer ·Seng Chuan Tang, Jurjen S. Lagas, Nienke A. G. Lankheet, Birk Poller, M. J. X. Hillebrand, Hilde Rosing, Jos H. Beijnen, Alfred H. Schinkel	2011	129
4	Prediction of Organic Anion-Transporting Polypeptide 1B1- and 1B3-Mediated Hepatic Uptake of Statins Based on Transporter Protein Expression and Activity Data Drug Metabolism and Disposition ·Annett Kunze, Jörg Huwyler, Gian Camenisch, Birk Poller	2014	94
5	Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects American Journal of Clinical Nutrition ·Robert E. Steinert, Birk Poller, Mariacristina Castelli, Jürgen Drewe, Christoph Beglinger	2010	76
6	Double-Transduced MDCKII Cells To Study Human P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Interplay in Drug Transport across the Blood−Brain Barrier Molecular Pharmaceutics ·Birk Poller, Els Wagenaar, Seng Chuan Tang, Alfred H. Schinkel	2011	59
7	Differential Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) on Axitinib Brain Accumulation and Oral Plasma Pharmacokinetics Drug Metabolism and Disposition ·Birk Poller, Dilek Iusuf, Rolf W. Sparidans, Els Wagenaar, Jos H. Beijnen, Alfred H. Schinkel	2011	58
8	Pharmacokinetics and Pharmacodynamic Effects of Oral GLP-1 and PYY3-36: A Proof-of-concept Study in Healthy Subjects Clinical Pharmacology & Therapeutics ·Christoph Beglinger, Birk Poller, Ehud Arbit, Cornelia Ganzoni, S. Gass, Isabel Gómez-Orellana, Jürgen Drewe	2008	45
9	Hypericum perforatum: Which Constituents may Induce Intestinal MDR1 and CYP3A4 mRNA Expression? Planta Medica ·Heike Gutmann, Birk Poller, Karin Berger Büter, Arabelle Pfrunder, W. Schaffner, Jürgen Drewe	2006	40
10	A Systematic In Vitro Investigation of the Inhibitor Preincubation Effect on Multiple Classes of Clinically Relevant Transporters Drug Metabolism and Disposition ·Péter Tátrai, Patrick Schweigler, Birk Poller, Norbert Domange, R.D. Wilde, Imad Hanna, Zsuzsanna Gáborik, Felix Huth	2019	40
11	Orally Administered Glucagon-Like Peptide-1 Affects Glucose Homeostasis Following an Oral Glucose Tolerance Test in Healthy Male Subjects Clinical Pharmacology & Therapeutics ·Robert E. Steinert, Birk Poller, Mariacristina Castelli, Kristen Friedman, Andreas Huber, Jürgen Drewe, Christoph Beglinger	2009	39
12	In Vitro–In Vivo Extrapolation Method to Predict Human Renal Clearance of Drugs Journal of Pharmaceutical Sciences ·Annett Kunze, Jörg Huwyler, Birk Poller, Heike Gutmann, Gian Camenisch	2014	33
13	P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Restrict Brain Accumulation of the Active Sunitinib Metabolite N-Desethyl Sunitinib Journal of Pharmacology and Experimental Therapeutics ·Seng Chuan Tang, Nienke A. G. Lankheet, Birk Poller, Els Wagenaar, Jos H. Beijnen, Alfred H. Schinkel	2012	33
14	Cytokine signaling in the human brain capillary endothelial cell line hCMEC/D3 Brain Research ·Elizaveta Fasler‐Kan, Claudia Suenderhauf, Natasha S. Barteneva, Birk Poller, Daniel Gygax, Jörg Huwyler	2010	28
15	Current In Vitro Methods to Determine Hepatic Kp uu : A Comparison of Their Usefulness and Limitations Journal of Pharmaceutical Sciences ·Julia Riede, Gian Camenisch, Jörg Huwyler, Birk Poller	2017	26
16	The application of organ-on-chip models for the prediction of human pharmacokinetic profiles during drug development Pharmacological Research ·Marit Keuper-Navis, Markus Walles, Birk Poller, Adam Myszczyszyn, Thomas K. van der Made, Joanne M. Donkers, Hossein Eslami Amirabadi, Martijn J. Wilmer, Saskia Aan, Bart Spee, Rosalinde Masereeuw, Evita van de Steeg	2023	26
17	Application of the extended clearance concept classification system (ECCCS) to predict the victim drug-drug interaction potential of statins Drug Metabolism and Personalized Therapy ·Annett Kunze, Birk Poller, Jörg Huwyler, Gian Camenisch	2015	24
18	In vitro P-glycoprotein efflux inhibition by atypical antipsychotics is in vivo nicely reflected by pharmacodynamic but less by pharmacokinetic changes Pharmacology Biochemistry and Behavior ·Ulrich Schmitt, Katrin M. Kirschbaum, Birk Poller, Manisha Kusch-Poddar, Jürgen Drewe, Christoph Hiemke, Heike Gutmann	2012	24
19	Novel insights into bile acid detoxification via CYP, UGT and SULT enzymes Toxicology in Vitro ·Vlasia Kastrinou Lampou, Birk Poller, Felix Huth, Audrey Fischer, Gerd A. Kullak‐Ublick, Michael Arand, Heiko S. Schadt, Gian Camenisch	2022	23
20	The extended clearance model and its use for the interpretation of hepatobiliary elimination data ADMET & DMPK ·Gian Camenisch, Julia Riede, Annett Kunze, Jörg Huwyler, Birk Poller, Kenichi Umehara	2015	23

About Birk Poller

Birk Poller is a scholar working on Pharmacology, Oncology, Pediatrics, Perinatology and Child Health, Endocrine and Autonomic Systems and Neurology, having authored 35 papers that have together received 1.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (23 papers), Pharmacological Effects and Toxicity Studies (12 papers), Pharmacogenetics and Drug Metabolism (11 papers), Drug-Induced Hepatotoxicity and Protection (6 papers), Diabetes Treatment and Management (4 papers), Computational Drug Discovery Methods (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Neuropeptides and Animal Physiology (2 papers). The work is most often cited by research in Pharmacology (254 citations), Oncology (684 citations), Neurology (172 citations), Pediatrics, Perinatology and Child Health (257 citations) and Endocrine and Autonomic Systems (69 citations). Birk Poller has collaborated with scholars based in Switzerland, United States and Netherlands. Frequent co-authors include Jörg Huwyler, Jürgen Drewe, Heike Gutmann, Stephan Krähenbühl, Gian Camenisch, Alfred H. Schinkel, Annett Kunze, Seng Chuan Tang, Jos H. Beijnen and Els Wagenaar. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Pharmaceutical Sciences, Clinical Pharmacology & Therapeutics, Clinical and Translational Science and European Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact